Table 5.
Group | Hexokinase (n moles of glucose-6-phosphate formed/min/mg/protein) | Aldolase (n moles of glyceraldehyde formed/min/mg protein) | Phosphoglucoisomerase (n moles of fructose formed/min/mg protein) |
---|---|---|---|
C | 397.26 ± 7.39 | 156.3 ± 7.13 | 49.32 ± 5.49 |
A | 103.36 ± 5.86 | 244.82 ± 30.7 | 27.32 ± 4.55 |
A + M100 | 228.62 ± 15.97∗ | 201.9 ± 11.56∗ | 33.28 ± 4.95∗ |
A + M200 | 333.8 ± 11.20∗ | 176.14 ± 8.75∗ | 41.24 ± 1.63∗ |
A + M500 | 401.4 ± 10.05∗ | 155.86 ± 14.2∗ | 49.28 ± 3.40∗ |
A + G500 | 213.86 ± 12.20∗ | 210.86 ± 9.94∗ | 30.4 ± 4.21∗ |
A + G750 | 325.9 ± 11.05∗ | 192.12 ± 11.25∗ | 38.64 ± 1.50∗ |
A + G1000 | 378.56 ± 21.88∗ | 157.64 ± 8.20∗ | 47.38 ± 2.30∗ |
M100 | 391.24 ± 8.56 | 161.74 ± 6.95 | 46.74 ± 6.56 |
M200 | 393.16 ± 8.91 | 152.58 ± 7.07 | 50.04 ± 4.43 |
M500 | 395.64 ± 6.87 | 151.68 ± 6.34 | 47.7 ± 3.08 |
G 500 | 396.44 ± 8.34 | 161.92 ± 5.79 | 48.76 ± 3.98 |
G 750 | 388.14 ± 2.53 | 159.62 ± 11.89 | 49.06 ± 4.04 |
G 1000 | 397.68 ± 7.185 | 150.08 ± 2.85 | 50.78 ± 3.64 |
∗ p < 0.05 indicates a significant difference from the disease group (C = control group, A = alloxan-treated group, M = metformin, A + M = alloxan + metformin, A + G = alloxan + Gynura, and G = G. procumbens).